Early experiences with edoxaban for stroke prevention in atrial fibrillation in the Southeast Asia region

Edoxaban, a once-daily, direct-acting oral anticoagulant, is approved to prevent stroke or systemic embolism in non-valvular atrial fibrillation (NVAF) and treat venous thromboembolism. The clinical benefit of edoxaban for stroke prevention in Asian patients with NVAF has been demonstrated in clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Diaz, Alejandro Bimbo, Chow, Jeremy, Hoo, Fan Kee, Koh, Kok Wei, Lee, Gary Chin Keong, Teo, Wee Siong, Venketasubramanian, Narayanaswamy, Wang, Chun-Chieh, Mehta, Radhika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2023
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499367/
https://www.ncbi.nlm.nih.gov/pubmed/37711730
http://dx.doi.org/10.7573/dic.2023-3-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499367/
https://www.ncbi.nlm.nih.gov/pubmed/37711730
http://dx.doi.org/10.7573/dic.2023-3-3

Ejemplares similares